Author Index: P
• ALL TAKING SOME OR SOME TAKING NONE? ASSESSING WHETHER DIFFERENT APPROACHES FOR MODELING DRUG COMPLIANCE AFFECT THE OPTIMAL DECISION FOR STATIN TREATMENT INITIATION
• USING MODELING TO PROJECT OPTMIAL CAROTID STENOSIS SCREENING PRACTICES
• CHOICE OF TIME SCALE FOR MODELING LONG-TERM SURVIVAL IN A COST-EFFECTIVENESS ANALYSIS: AN ILLUSTRATION
• METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
• USING MODELING TO PROJECT OPTMIAL CAROTID STENOSIS SCREENING PRACTICES
• CHOICE OF TIME SCALE FOR MODELING LONG-TERM SURVIVAL IN A COST-EFFECTIVENESS ANALYSIS: AN ILLUSTRATION
• METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
• A STATED CHOICE EXPERIMENT TO INVESTIGATE PREFERENCES FOR INFORMATION PROVISION IN NEWBORN BLOODSPOT SCREENING PROGRAMMES
• INVESTIGATING THE FRAMING-EFFECTS OF RISK ATTRIBUTES IN A DISCRETE CHOICE EXPERIMENT FOR A NATIONAL BREAST SCREENING PROGRAMME
• USING EYE-TRACKING METHODS TO INVESTIGATE THE FRAMING OF RISK ATTRIBUTES IN DISCRETE CHOICE EXPERIMENTS
• INVESTIGATING THE FRAMING-EFFECTS OF RISK ATTRIBUTES IN A DISCRETE CHOICE EXPERIMENT FOR A NATIONAL BREAST SCREENING PROGRAMME
• USING EYE-TRACKING METHODS TO INVESTIGATE THE FRAMING OF RISK ATTRIBUTES IN DISCRETE CHOICE EXPERIMENTS
• CURRENT TREATMENT FOR CHRONIC HEPATITIS B (CHB): A SYSTEMATIC REVIEW AND A NETWORK META-ANALYSIS
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
• IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
• FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
• COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS
• DECISION MODELLING USING R
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
• IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
• FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
• COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS
• DECISION MODELLING USING R